Abstract
DNA nanomaterials offer promising advancements in addressing the challenges of rheumatoid arthritis (RA) through targeted drug delivery, biomarker detection, and therapeutic innovation.
Funding Information
  • National Natural Science Foundation of China (82101077)
  • National Natural Science Foundation of China (82201131)
  • Sichuan University (RCDWJS2023-5)
  • Fundamental Research Funds for the Central Universities
  • China Postdoctoral Science Foundation (2023T160455)
  • China Postdoctoral Science Foundation (2021M692271)

This publication has 140 references indexed in Scilit: